Literature DB >> 17177755

Pregabalin for pain management.

Noor M Gajraj1.   

Abstract

Pregabalin is a new analog of the neurotransmitter gamma-aminobutyric acid (GABA). It is an alpha2-delta (alpha2-delta) ligand that has analgesic, anticonvulsant, and anxiolytic activity. Alpha2-delta is an auxiliary protein associated with voltage-gated calcium channels. Pregabalin binds potently to the alpha2-delta subunit resulting in modulation of calcium channels and reduction in the release of several neurotransmitters, including glutamate, norepinephrine, serotonin, dopamine, and substance P. This review discusses the pharmacology of this medication as well as available studies in patients.

Entities:  

Year:  2005        PMID: 17177755     DOI: 10.1111/j.1533-2500.2005.05205.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  13 in total

1.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 2.  The determination and application of fixed-dose analgesic combinations for treating multimodal pain.

Authors:  Robert B Raffa; Joseph V Pergolizzi; Ronald J Tallarida
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

3.  Effectiveness of preanesthetic administration of gabapentin on sedative action during intravenous sedation with propofol.

Authors:  Rumiko Hosokawa; Shinichi Ito; Jun Hirokawa; Yu Oshima; Takeshi Yokoyama
Journal:  J Anesth       Date:  2018-09-20       Impact factor: 2.078

4.  Sedative effects of oral pregabalin premedication on intravenous sedation using propofol target-controlled infusion.

Authors:  Noriko Karube; Shinichi Ito; Saori Sako; Jun Hirokawa; Takeshi Yokoyama
Journal:  J Anesth       Date:  2017-05-02       Impact factor: 2.078

5.  The effects of co-administration of pregabalin and vitamin E on neuropathic pain induced by partial sciatic nerve ligation in male rats.

Authors:  Manzumeh-Shamsi Meymandi; Gholamreza Sepehri; Mona Abdolsamadi; Mohammad Shaabani; Gioia Heravi; Omid Yazdanpanah; Mohammadmehdi-Moeini Aghtaei
Journal:  Inflammopharmacology       Date:  2017-02-23       Impact factor: 4.473

Review 6.  Neuromodulators for the treatment of headache disorders and fibromyalgia.

Authors:  Abouch V Krymchantowski; Juline Bryson; Richard B Lipton; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2008-10

7.  Gabapentin for decerebrate rigidity: a case report.

Authors:  Chuen-Der Kao; Jen-Tse Chen; Kuan-Lin Lai; Jiun-Bin Chang; Zin-An Wu; Kwong-Kum Liao
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

8.  Pregabalin Did Not Improve Pain Management After Spinal Fusions.

Authors:  Michael K Urban; Kristy M Labib; Shane C Reid; Amanda K Goon; Valeria Rotundo; Frank P Cammisa; Federico P Girardi
Journal:  HSS J       Date:  2017-11-06

9.  Pregabalin-induced self-harm behavior.

Authors:  Vishal R Tandon; Vivek Mahajan; Zahid H Gillani; Annil Mahajan
Journal:  Indian J Pharmacol       Date:  2013 Nov-Dec       Impact factor: 1.200

10.  The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial.

Authors:  Razieh Avan; Ghasem Janbabaei; Narjes Hendouei; Abbas Alipour; Samaneh Borhani; Nasim Tabrizi; Ebrahim Salehifar
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.